187 related articles for article (PubMed ID: 10880412)
1. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition.
Prasad A; Narayanan S; Husain S; Padder F; Waclawiw M; Epstein N; Quyyumi AA
Circulation; 2000 Jul; 102(1):35-41. PubMed ID: 10880412
[TBL] [Abstract][Full Text] [Related]
2. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
Prasad A; Husain S; Quyyumi AA
J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
[TBL] [Abstract][Full Text] [Related]
3. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity.
Prasad A; Narayanan S; Waclawiw MA; Epstein N; Quyyumi AA
J Am Coll Cardiol; 2000 Nov; 36(5):1579-86. PubMed ID: 11079661
[TBL] [Abstract][Full Text] [Related]
4. Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans.
Prasad A; Husain S; Schenke W; Mincemoyer R; Epstein N; Quyyumi AA
J Am Coll Cardiol; 2000 Nov; 36(5):1467-73. PubMed ID: 11079644
[TBL] [Abstract][Full Text] [Related]
5. Effect of enalaprilat on nitric oxide activity in coronary artery disease.
Prasad A; Husain S; Quyyumi AA
Am J Cardiol; 1999 Jul; 84(1):1-6. PubMed ID: 10404842
[TBL] [Abstract][Full Text] [Related]
6. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans.
Butler R; Morris AD; Burchell B; Struthers AD
Hypertension; 1999 May; 33(5):1164-8. PubMed ID: 10334805
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin.
Ohira N; Matsumoto T; Tamaki S; Takashima H; Tarutani Y; Yamane T; Yasuda Y; Horie M
Hypertens Res; 2004 Jan; 27(1):39-45. PubMed ID: 15055254
[TBL] [Abstract][Full Text] [Related]
8. [Effect of angiotensin converting enzyme genotype on endothelial function in healthy subjects].
Tanriverdi H; Evrengül H; Dursunoğlu D; Tüzün N; Turgut S; Turgut G; Tanriverdi S; Kiliç D; Kiliç M
Anadolu Kardiyol Derg; 2008 Feb; 8(1):2-6. PubMed ID: 18258525
[TBL] [Abstract][Full Text] [Related]
9. Exclusion of the ACE D/I gene polymorphism as a determinant of endothelial dysfunction.
Rossi GP; Taddei S; Virdis A; Ghiadoni L; Albertin G; Favilla S; Sudano I; Pessina AC; Salvetti A
Hypertension; 2001 Feb; 37(2):293-300. PubMed ID: 11230288
[TBL] [Abstract][Full Text] [Related]
10. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion.
Piana RN; Wang SY; Friedman M; Sellke FW
Circulation; 1996 Feb; 93(3):544-51. PubMed ID: 8565174
[TBL] [Abstract][Full Text] [Related]
12. ACE genotype and endothelium-dependent vasodilation of conduit arteries and forearm microcirculation in humans.
Arcaro G; Solini A; Monauni T; Cretti A; Brunato B; Lechi A; Fellin R; Caputo M; Cocco C; Bonora E; Muggeo M; Bonadonna RC
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1313-9. PubMed ID: 11498459
[TBL] [Abstract][Full Text] [Related]
13. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
Winkelmann BR; Nauck M; Klein B; Russ AP; Böhm BO; Siekmeier R; Ihnken K; Verho M; Gross W; März W
Ann Intern Med; 1996 Jul; 125(1):19-25. PubMed ID: 8644984
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors.
Celermajer DS; Sorensen KE; Barley J; Jeffrey S; Carter N; Deanfield J
Atherosclerosis; 1994 Nov; 111(1):121-6. PubMed ID: 7840807
[TBL] [Abstract][Full Text] [Related]
15. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction in patients with chest pain and normal coronary arteries.
Quyyumi AA; Cannon RO; Panza JA; Diodati JG; Epstein SE
Circulation; 1992 Dec; 86(6):1864-71. PubMed ID: 1451258
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme DD polymorphism is associated with poor coronary collateral circulation in patients with coronary artery disease.
Ceyhan K; Kadi H; Celik A; Burucu T; Koc F; Sogut E; Sahin S; Onalan O
J Investig Med; 2012 Jan; 60(1):49-55. PubMed ID: 22064603
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.
Arbustini E; Grasso M; Fasani R; Klersy C; Diegoli M; Porcu E; Banchieri N; Fortina P; Danesino C; Specchia G
Br Heart J; 1995 Dec; 74(6):584-91. PubMed ID: 8541160
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
Chalon S; Moreno H; Hoffman BB; Blaschke TF
Clin Pharmacol Ther; 1999 Mar; 65(3):295-303. PubMed ID: 10096262
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine improves coronary and peripheral vascular function.
Andrews NP; Prasad A; Quyyumi AA
J Am Coll Cardiol; 2001 Jan; 37(1):117-23. PubMed ID: 11153725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
